News|Videos|June 13, 2023
Transduction for AAV with Sean Hart
Author(s)Chris Spivey
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured.
Advertisement
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured. The full discussion can and more can be viewed
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs
2
West Launches New Prefillable Syringe System that Streamlines Biologic Delivery
3
State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment
4
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
5